ArticleTranslational lung cancer research2024

HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors.

Meejeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.